ArticleOral and maxillofacial surgery2025
The impact of COVID-19 on facial laceration trends: a comparative analysis of pre- and intra-pandemic data.
Article in Oral and maxillofacial surgery, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Alcohol-Only and Drug/Medication-Only Product-Associated Facial Injury Encounters Across COVID-19 Periods: A Public CPSC NEISS Study, 2019-2023.Craniomaxillofacial trauma & reconstruction · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundThis study explores the impact of the COVID-19 pandemic on the patterns, mechanisms, and clinical management of facial lacerations. By comparing data from pre-pandemic and intra-pandemic periods, it aims to elucidate how COVID 19 influenced maxillofacial trauma care. MATERIALS AND
methodsA retrospective analysis was conducted on 747 patients treated for facial lacerations at a maxillofacial trauma center. Data were collected for two periods: pre-COVID (February 2019-January 2020) and intra-COVID (February 2020-January 2021). Demographics, injury characteristics, mechanisms, and treatment modalities were analyzed.
resultsDuring the intra-COVID period, the proportion of fall-related facial lacerations nearly doubled (18.6% vs. 39.2%, p < 0.001), while injuries associated with alcohol consumption (43.4% vs. 12.5%, p < 0.001) and interpersonal violence (22.5% vs. 8.3%, p < 0.001) declined markedly. The sex distribution shifted significantly, with female patients comprising a higher proportion of cases during the pandemic (33.3% vs. 45.8%, p < 0.001). Temporal patterns also changed, as morning injuries became substantially more frequent (11.6% vs. 40.0%, p < 0.001). Syncopal events linked to viral infections increased significantly (3.9% vs. 15.0%, p < 0.001). In terms of clinical management, the use of radiographic imaging (69.8% vs. 60.0%, p = 0.005) and tetanus booster administration (42.6% vs. 28.3%, p < 0.001) both declined during the pandemic period.
conclusionThe COVID-19 pandemic significantly altered the epidemiology and clinical management of facial lacerations, as evidenced by shifts in trauma mechanisms, patient demographics, and resource use. These findings highlight the need for adaptive trauma care strategies during public health crises.
Indexed as
Identifiers
40407841What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.